Status:
UNKNOWN
Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)
Lead Sponsor:
EicOsis Human Health Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective, single center, observational, cohort study of patients to (1) describe the kinetics and temporal relationship of changes in eicosanoid and cytokine mediators in patients w...
Eligibility Criteria
Inclusion
- Admitted to a hospital with symptoms suggestive of COVID-19.
- Confirmed infection with SARS-CoV-2 as determined by polymerase chain reaction (PCR) or other commercial or public health assay in the 72 hours prior to hospital admission or any time during hospital admission.
- Subject (or legally authorized representative) provides written informed consent prior to initiation of any study procedures.
- Understands and agrees to comply with planned study procedures.
- Agrees to the collection of whole blood samples.
Exclusion
- Inability to obtain informed consent.
- Anticipated transfer to another hospital which is not a study site within 48 hours.
- Inability to obtain sequential blood samples due to patient's characteristics (i.e. difficult vascular access).
- Obstetric patients.
- Prisoners.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04452942
Start Date
July 1 2020
End Date
April 1 2021
Last Update
July 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University Hospital
New York, New York, United States, 11794